Mifepristone Maker Asks Supreme Court to Restore Mail-Order Prescriptions
The emergency bid could shape access to abortion pills through telehealth across the United States.
Overview
- Danco Laboratories, which filed with the Supreme Court on Saturday, seeks to pause a New Orleans–based appeals court order that halted mailing prescriptions for the abortion pill mifepristone.
- Following Friday’s injunction from the federal court in New Orleans, the 2023 federal policy that allowed telehealth prescribing and shipment of mifepristone is on hold.
- Louisiana brought the case, arguing that mail delivery enables illegal abortions in the state, which bans the procedure under its laws.
- Danco said the lower court’s order would create immediate confusion for patients and clinicians making time‑sensitive medical decisions.
- The Supreme Court has not yet acted, and its response could quickly reset the rules for prescribing and shipping this widely used pill nationwide.